Company news
HemoGenyx Pharmaceuticals PLC news in 2019
HemoGenyx Pharmaceuticals PLC's news releases, calls and decks from 2019, newest first.
Operational Update
November 18, 2019
Presentation at the Investival Showcase
November 12, 2019
Presentation at the NY Oncology Investor Conf.
November 6, 2019
Research Agreement with Global Pharma Company
October 23, 2019
Presentation at NY Stem Cell Foundation conference
October 21, 2019
Hemogenyx scientific advisor receives Lasker Award
September 12, 2019
CDX Patent Application
July 12, 2019
Development of ApbHC
June 24, 2019
CDX Effective as Conditioning Therapeutic in vivo
June 12, 2019
CDX Antibody is Effective against AML in vivo
June 5, 2019
CDX Antibody is Effective against ALL in vitro
May 30, 2019
Posting of Annual Report and Notice of AGM
May 28, 2019
Variation of Terms of Warrant Instrument
May 15, 2019
Final Results for the Year Ended 31 December 2018
April 29, 2019
Presentation at Cancer Immunotherapy Conference
January 30, 2019